Dr. Otto F Mares, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 502 S Washington St, Du Quoin, IL 62832 Phone: 618-542-3032 Fax: 314-667-5670 |
Samantha Kay Gross, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1226 S Washington St, Du Quoin, IL 62832 Phone: 618-542-8832 |
Richard Louis Weinberg, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 701 N Washington St, Du Quoin, IL 62832 Phone: 618-542-5482 Fax: 618-542-5483 |
Dr. Isaac E. Davison, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1226 S Washington St, Du Quoin, IL 62832 Phone: 618-542-8832 Fax: 618-542-9255 |
Dr. Kasey Maria Pyron, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 502 S Washington St, Du Quoin, IL 62832 Phone: 618-542-3032 Fax: 618-542-3036 |
News Archive
In children and adults with Friedreich's ataxia, an inherited disease that causes damage to the nervous system, a loss of coordination typically progresses to muscle weakness and can involve vision, diabetes, and other problems over the course of several years.
Prof. Claudio Cuello at McGill University and his collaborators have genetically manipulated rats that can emulate Alzheimer's disease in humans, enabling research that will include the development of new treatments. Alzheimer's is a devastating brain condition leading to a progressive decline of memory and other brain functions. Although research mice have been developed in the past, rats are more intelligent than other rodents and the behavior of these rats is rich and predictable, which means that for the first time researchers will be able to detect and study the evolution of learning and memory deficits.
Washington Hospital, the local provider of healthcare for the Tri-City area and one of the region's best medical facilities, today opened a state of the art Central Utility Plant that will provide energy for the campus' expansion and modernization for decades to come.
Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology - demonstrate that the Resolute drug-eluting stent from Medtronic, Inc., provides a positive and persistent treatment effect for a wide variety of patients with coronary artery disease.
CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has received approval of its Investigational Device Exemption (IDE) for PerClot from the United States Food and Drug Administration.
› Verified 6 days ago